Inventor · disambiguated record
Thale Jarvis
Also filed as: JARVIS THALE · JARVIS THALE C · JARVIS THALE CROSS
22 granted patents·7 pending applications·1,491 citations·filing 1995–2019
96Inventor score
Files withRIBOZYME PHARM INC8SOMALOGIC INC7GUILES JOSEPH3SIRNA THERAPEUTICS INC2BIOVECTOR THERAPEUTICS SA1
Top patents by PatentIndex Score
29 records- 0198US6673611B2Nucleic acid molecules with novel chemical compositions capable of modulating gene expressionSIRNA THERAPEUTICS INC·Filed 2001·Granted Jan 6, 2004·218 cites·17 claims
- 0298US5998203AEnzymatic nucleic acids containing 5'-and/or 3'-cap structuresRIBOZYME PHARM INC·Filed 1996·Granted Dec 7, 1999·784 cites·41 claims
- 0397US10221421B2Post-selec modification methodsSOMALOGIC INC·Filed 2017·Granted Mar 5, 2019·39 cites·6 claims
- 0496US9382533B2Method for generating aptamers with improved off-ratesSOMALOGIC INC·Filed 2015·Granted Jul 5, 2016·16 cites·19 claims
- 0596US8975026B2Method for generating aptamers with improved off-ratesZICHI DOMINIC·Filed 2010·Granted Mar 10, 2015·45 cites·29 claims
- 0694US8148380B2Antibacterial amide and sulfonamide substituted heterocyclic urea compoundsGUILES JOSEPH·Filed 2008·Granted Apr 3, 2012·46 cites·23 claims
- 0793US5646042AC-myb targeted ribozymesRIBOZYME PHARM INC·Filed 1995·Granted Jul 8, 1997·123 cites·220 claims
- 0891US5877021AB7-1 targeted ribozymesRIBOZYME PHARM INC·Filed 1996·Granted Mar 2, 1999·88 cites·11 claims
- 0986US9701967B2Aptamers to PDGF and VEGF and their use in treating PDGF and VEGF mediated conditionsSOMALOGIC INC·Filed 2016·Granted Jul 11, 2017·4 cites·10 claims
- 1083US8716320B2Antibacteriall heterocyclic ureasGUILES JOSEPH·Filed 2007·Granted May 6, 2014·4 cites·25 claims
- 1183US6586238B1Enzymatic nucleic acids containing 5′-and or 3′-cap structuresRIBOZYME PHARM INC·Filed 1999·Granted Jul 1, 2003·43 cites·20 claims
- 1282US9410156B2Aptamers to PDGF and VEGF and their use in treating PDGF and VEGF mediated conditionsSOMALOGIC INC·Filed 2013·Granted Aug 9, 2016·4 cites·24 claims
- 1382US6194150B1Nucleic acid based inhibition of CD40RIBOZYME PHARM INC·Filed 1998·Granted Feb 27, 2001·45 cites·26 claims
- 1479US8293919B2Antibacterial sulfone and sulfoxide substituted heterocyclic urea compoundsGUILES JOSEPH·Filed 2008·Granted Oct 23, 2012·4 cites·19 claims
- 1565US11221340B2Lung cancer biomarkers and uses thereofSOMALOGIC INC·Filed 2018·Granted Jan 11, 2022·0 cites·5 claims
- 1665US11208663B2Post-selex modification methodsSOMALOGIC INC·Filed 2019·Granted Dec 28, 2021·0 cites·9 claims
- 1759US6103890AEnzymatic nucleic acids that cleave C-fosRIBOZYME PHARM INC·Filed 1997·Granted Aug 15, 2000·12 cites·19 claims
- 1858US5817796AC-myb ribozymes having 2'-5'-linked adenylate residuesFiled 1995·Granted Oct 6, 1998·10 cites·3 claims
- 1958US2005176018A1Chemically modified double stranded nucleic acid moleculesSIRNA THERAPEUTICS INC·Filed 2003·Application pending·0 cites
- 2057US2005074760A1Enzymatic nucleic acids containing 5'-and/or 3'-cap structuresRIBOZYME PHARM INC·Filed 2003·Application pending·0 cites
- 2150US2003207837A1Method and reagent for the induction of graft tolerance and reversal of immune responsesRIBOZYME PHARM INC·Filed 2003·Application pending·0 cites
- 2250US2013116150A1Lung Cancer Biomarkers and Uses ThereofWILCOX SHERI·Filed 2011·Application pending·0 cites
- 2344US6214621B1Conjugates of a particle vector and oligonucleotides, process for their preparation, and pharmaceutical compositions containing themBIOVECTOR THERAPEUTICS SA·Filed 1997·Granted Apr 10, 2001·6 cites·30 claims
- 2444US2003013105A1Methods for identifying drugs specific for known molecular targets using model compounds specific for the molecular targetsFiled 2002·Application pending·0 cites
- 2543US2003087847A1Method and reagent for the inhibition of checkpoint kinase-1 (Chk1) enzymeONYX PHARMA INC·Filed 2001·Application pending·0 cites
- 2643US2003134806A1Method and reagent for the inhibition of gridFiled 2001·Application pending·0 cites
- 2740US11655225B2Antimycobacterial heterocyclic amidesCRESTONE INC·Filed 2019·Granted May 23, 2023·0 cites·8 claims
- 2840US8431376B2Bacterial replication systems and methodsJARVIS THALE CROSS·Filed 2005·Granted Apr 30, 2013·0 cites·1 claims
- 2939US9206429B2Aptamers that bind to IL-6 and their use in treating or diagnosing IL-6 mediated conditionsSOMALOGIC INC·Filed 2014·Granted Dec 8, 2015·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Thale Jarvis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →